Anxiolytic-like effects of PHCCC, an allosteric modulator of mGlu 4 receptors, in rats

European Journal of Pharmacology

Volumn 498, Issue 1-3, 2004, Pages 153-156

  Stachowicz, Katarzyna ^a   Kłak, Kinga ^a   Kłodzińska, Aleksandra ^a   Chojnacka Wojcik, Ewa ^a   Pilc, Andrzej ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Allosteric mGlu 4 receptor modulator; Amygdala; Anxiety; mGlu 1 receptor antagonist

Indexed keywords

7 (HYDROXYIMINO)CYCLOPROPA[B]CHROMEN 1A CARBOXYLATE ETHYL ESTER; ESTER DERIVATIVE; METABOTROPIC RECEPTOR 4; METABOTROPIC RECEPTOR ANTAGONIST; N PHENYL 7 (HYDROXYIMINO)CYCLOPROPA[B]CHROMEN 1A CARBOXAMIDE; UNCLASSIFIED DRUG;

ALLOSTERISM; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; FLUID INTAKE; MALE; MODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ALCOHOL DRINKING; ALLOSTERIC REGULATION; AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BENZOPYRANS; CHROMONES; CONFLICT (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING BEHAVIOR; ELECTROSHOCK; MALE; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 4444250357     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.07.001     Document Type: Article

References (14)

1. E. Chojnacka-Wojcik, A. Klodzinska, and A. Pilc Glutamate receptor ligands as anxiolytics Curr. Opin. Investig. Drugs 2 2001 1112 1119
2. A.D. Conigrave, and A.H. Franks Allosteric activation of plasma membrane receptorsâ€"physiological implications and structural origins Prog. Biophys. Mol. Biol. 81 2003 219 240
3. P.J. Conn, and J.P. Pin Pharmacology and functions of metabotropic glutamate receptors Annu. Rev. Pharmacol. Toxicol. 37 1997 205 237
4. M. Davis The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety Trends Pharmacol. Sci. 13 1992 35 41
5. C. Grillon, J. Cordova, L.R. Levine, and C.A. Morgan Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans Psychopharmacology 168 2003 446 454
6. D.R. Helton, J.P. Tizzano, J.A. Monn, D.D. Schoepp, and M.J. Kallman Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors J. Pharmacol. Exp. Ther. 284 1998 651 660
7. A. Klodzinska, E. Chojnacka-Wójcik, A. Palucha, P. Branski, P. Popik, and A. Pilc Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models Neuropharmacology 38 1999 1831 1839
8. M. Maj, V. Bruno, Z. Dragic, R. Yamamoto, G. Battaglia, W. Inderbitzin, N. Stoehr, T. Stein, F. Gasparini, I. Vranesic, R. Kuhn, F. Nicoletti, and P.J. Flor (-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection Neuropharmacology 45 2003 895 906
9. M.J. Marino, D.L. Williams, J.A. OBrien, O. Valenti, T.P. McDonald, M.K. Clements, R.P. Wang, A.G. DiLella, J.F. Hess, G.G. Kinney, and P.J. Conn Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment Proc. Natl. Acad. Sci. U. S. A. 100 2003 13668 13673
10. A. Palucha, E. Tatarczynska, P. Branski, B. Szewczyk, J.M. Wieronska, A. Klodzinska, E. Chojnacka-Wojcik, G. Nowak, and A. Pilc Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats Neuropharmacology 46 2004 151 159
11. D.D. Schoepp Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system J. Pharmacol. Exp. Ther. 299 2001 12 20
12. E. Tatarczynska, A. Klodzinska, B. Kroczka, E. Chojnackawojcik, and A. Pilc The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration Psychopharmacology 158 2001 94 99
13. E. Tatarczynska, A. Palucha, B. Szewczyk, E. Chojnacka-Wojcik, J. Wieronska, and A. Pilc Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4- tricarboxylic acid (ACPT-I) in rats Pol. J. Pharmacol. 54 2002 707 710
14. J.R. Vogel, B. Beer, and D.E. Clody A simple and reliable conflict procedure for testing anti-anxiety agents Psychopharmacologia 21 1971 1 7